Skip to content
healthcare.dev

UNLOXCYT

NDC 70095-130, cosibelimab, injection, solution, from Sun Pharmaceutical Industries, Inc..

Product NDC
70095-130
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761297
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70095-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • COSIBELIMAB300 mg/5mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Programmed Death Ligand-1 Antagonists [MoA]; Programmed Death Ligand-1 Blocker [EPC]; Programmed Death Ligand-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
70095-130-01700950130011 VIAL, GLASS in 1 CARTON (70095-130-01) / 5 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/06bdadd5-d2db-406f-a3f8-de47f48a52e3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70095-130

Use it

Look up 70095-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70095-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70095-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.